HOMECONTACTSITE MAPSEARCH

Stock Information
NASDAQ:INFI
$6.36   - 0.05
Mar 11, 2010
4:00 PM ET
Quotes delayed at least 20 minutes. Data provided by eSignal.
Investors and Media Relations

The mission of Infinity Pharmaceuticals, Inc. is to discover, develop, and deliver to patients best-in-class medicines for the treatment of cancer and related conditions. We have built a pipeline of innovative product candidates for multiple indications, all of which represent proprietary applications of our expertise in small molecule drug discovery and development.


Events

Mar 9, 2010
30th Annual Cowen Health Care Conference

Feb 10, 2010
Infinity Pharmaceuticals Fourth Quarter 2009 Results

more »

Annual Report


Click here to view the 2008 Annual Report PDF


Recent Releases

Mar 10, 2010
Infinity's Innovative Hedgehog Pathway Inhibitor Program to be Highlighted at Upcoming Conferences

Mar 2, 2010
Infinity to Present at Cowen Health Care Conference

more »

Request Investor Kit
Shareholder Briefcase
Receive Email Alerts
Subscribe to News
Search
© 2001-2010 Infinity Pharmaceuticals, Inc. All rights reserved. | Terms | Forward Looking Statements | Privacy